Condition
Renin-Angiotensin System
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
P 4 (1)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05418361CompletedPrimary
The Effect of RAAS Blockers on ACE2 Levels
NCT03489993Completed
FGF23 and Angiotensin-(1-7) in Hypophosphatemia (GAP)
NCT02378064Phase 4Completed
Comparison of Fimasartan Versus Amlodipine Therapy on Carotid PlaquE Inflammation
NCT03317925Completed
Renal Transplant Injury and the Renin-Angiotensin System in Kids (RETASK)
Showing all 4 trials